The industry’s first implementation of an infusion pump drug library collaboration with FDB.
BETHLEHEM, PA – December 3, 2015 – B. Braun Medical Inc. will offer healthcare professionals extensive clinical support resources for drug libraries by collaborating with a leading provider of drug knowledge, First Databank (FDB). This represents the industry’s first implementation of an infusion pump drug library collaboration with FDB.
B. Braun Medical has entered into an innovative agreement with FDB, whose drug information helps healthcare professionals make precise medication-related decisions. FDB’s evidence-based Infusion Knowledge™ will power B. Braun Medical’s DoseGuard™ drug library dose error reduction software within the company’s second-generation, large-volume Infusomat® Space Pump.
“Our innovative drug library software furthers our commitment to reducing medication errors and improving patient outcomes,” said Mike Golebiowski, Vice President of Marketing, Automation and Infusion Systems at B. Braun Medical. “This collaboration with FDB will give healthcare professionals enhanced drug library configuration management and clinical support tools.”
Key elements of FDB’s added capabilities include:
“Pharmacists, nurses, and physicians are working harder than ever and are challenged to keep up-to-date on new and changing drug dosing information for IV medications,” said Bob Katter, Executive Vice President for FDB. “We are pleased to be working with B. Braun to bring FDB’s evidenced-based Infusion Knowledge content and unique collaboration tools to make it easier and faster to create and manage a drug library for smart pumps for these busy professionals.”
B. Braun Medical will be highlighting its Synchronized Intelligence™ Infusion Platform and DoseGuard drug library at its booth #2147 during the American Society of Health-System Pharmacists conference in New Orleans, La., Dec. 6-10.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is part of the B. Braun Group of Companies in the U.S., which is headquartered in Bethlehem, Pa., and includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 54,000 employees in more than 60 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
To learn more about B. Braun Medical, visit www.BBraunUSA.com